Table 3.
Factors associated with a linkage to care
| Variables | Proportion | P value (exact test) | |
|---|---|---|---|
| Sex | Male | 29% (6/21) | 0.5 |
| Female | 22% (2/9) | ||
| Age group | 20–30 | 14% (2/14) | 0.2 |
| > 30 | 38% (6/16) | ||
| Education | No secondary | 36% (4/11) | 0.3 |
| Secondary or above | 21% (4/19) | ||
| Year screened | 2003–2010 | 42% (5/12) | 0.1 |
| 2011–2014 | 17% (3/18) | ||
| Motivation for screening | Passive | 17% (3/18) | 0.1 |
| Active | 42% (5/12) | ||
| Place of screening result disclosure | Traditional healer | 0% (0/2) | 0.04 |
| Blood centers | 15% (3/20) | ||
| Hospitals/clinics | 57% (4/7) | ||
| World Hepatitis Day | 100% (1/1) | ||
| Told of antiviral therapy at screening disclosure | No: told that no treatment exists | 0% (0/5) | 0.002 |
| No: patient told nothing | 19% (4/21) | ||
| Yes | 100% (4/4) | ||
| Told of liver specialist at screening disclosure | No | 9% (2/22) | 0.001 |
| Yes | 75% (6/8) | ||
| Told of traditional healer or medicine at screening disclosure | No | 36% (8/22) | 0.07 |
| Yes | 0% (0/8) | ||